Stricken language would be deleted from and underlined language would be added to present law.
Act 634 of the Regular Session
*JMB177* 02/27/2025 11:04:58 AM JMB177
State of Arkansas 1
95th General Assembly A Bill 2
Regular Session, 2025 HOUSE BILL 1619 3
4
By: Representative Gramlich 5
By: Senator Irvin 6
7
For An Act To Be Entitled 8
AN ACT TO SET ADMINISTRATION FEES UNDER THE ARKANSAS 9
MEDICAID PROGRAM FOR IMMUNIZATIONS AND MONOCLONAL 10
ANTIBODIES FOR RESPIRATORY SYNCYTIAL VIRUS DISEASE; 11
TO PROVIDE CIVIL IMMUNITY FOR ADMINISTRATION OF 12
IMMUNIZATIONS AND MONOCLONAL ANTIBODIES FOR 13
RESPIRATORY SYNCYTICAL VIRUS DISEASE; AND FOR OTHER 14
PURPOSES. 15
16
17
Subtitle 18
TO SET ADMINISTRATION FEES UNDER THE 19
ARKANSAS MEDICAID PROGRAM FOR 20
IMMUNIZATIONS AND MONOCLONAL ANTIBODIES 21
FOR RESPIRATORY SYNCYTIAL VIRUS DISEASE; 22
AND TO PROVIDE CIVIL IMMUNITY. 23
24
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: 25
26
SECTION 1. Arkansas Code Title 20, Chapter 77, Subchapter 4, is 27
amended to add an additional section to read as follows: 28
20-77-408. Administrative fees for immunizations and monoclonal 29
antibodies for respiratory syncytial virus disease — Definition. 30
(a) As used in this section, "respiratory syncytial virus disease" 31
means a respiratory infection of the nose, throat, and lungs caused by the 32
respiratory syncytial virus. 33
(b) The Arkansas Medicaid Program shall reimburse an administration 34
fee that is equal to one hundred percent (100%) of the maximum administration 35
fee of the Vaccines for Children Program for this state for administration of 36 HB1619
2 02/27/2025 11:04:58 AM JMB177
an immunization or monoclonal antibody used for long -lasting protection from 1
respiratory syncytial virus disease in infants and toddlers, regardless of 2
the category in which the beneficiary receiving the immunization or 3
monoclonal antibody is enrolled, including without limitation the Medicaid 4
Provider-Led Organized Care Act, § 20 -77-2701 et seq. 5
(c) This section does not require a hospital licensed under § 20 -9-213 6
to provide any new or additional service related to administering the 7
immunization or monoclonal antibody used for long -lasting protection from 8
respiratory syncytial virus disease in infants and toddlers. 9
(d) The Department of Human Services shall apply for any federal 10
waiver, Medicaid state plan amendment, or other authority necessary to 11
implement this section. 12
13
SECTION 2. Arkansas Code Title 16, Chapter 114, Subchapter 2, is 14
amended to add an additional section to read as follows: 15
16-114-214. Immunity related to administration of immunization or 16
monoclonal antibody used for long -lasting protection from respiratory 17
syncytial virus disease — Definition. 18
(a) As used in this section, "respiratory syncytial virus disease" 19
means a respiratory infection of the nose, throat, and lungs caused by the 20
respiratory syncytial virus. 21
(b)(1) A person or entity that prescribes, dispenses, administers, or 22
is otherwise involved in the administration of an immunization or monoclonal 23
antibody used for long -lasting protection from respiratory syncytial virus 24
disease in infants and toddlers to an eligible patient is immune from civil 25
liability. 26
(2) A person or entity is not immune from civil liability for 27
actions taken during the administration of an immunization or monoclonal 28
antibody that: 29
(A) Are grossly negligent, reckless, or willful; or 30
(B) Are not taken in good faith and with reasonable care. 31
32
33
APPROVED: 4/16/25 34
35
36